Skip to main content
SpringerLink
Log in

Thromboprophylaxis in orthopaedic surgery

  • Chapter
Handbook of Thromboprophylaxis

  • 644 Accesses

Abstract

Some orthopaedic procedures probably carry no risk of thrombosis (e.g. upper limb surgery), whereas others carry a particularly high risk (e.g. revision hip surgery). Total hip replacement, total knee replacement and hip fracture have been the most widely studied procedures. The rate of fatal PE, without prophylaxis, is around 0.4% for total hip replacement and total knee replacement, and is probably higher for hip fracture. The symptomatic DVT rate for total hip replacement is around 4%. It may be higher for total knee replacement, although the similarity between postoperative and thrombotic swelling or calf pain confounds diagnosis. The frequency of chronic venous insufficiency, an important longer-term outcome, is unknown but is likely to be raised in those with asymptomatic DVT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2008; 133(6, Suppl):381S–453S.

    Article  PubMed  CAS  Google Scholar 

  2. Guyatt G, Schünemann HJ, Cook D, et al. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(Suppl):179S–187S.

    Article  PubMed  Google Scholar 

  3. Turpie AGG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery. Arch Int Med 2002; 162:1833–1840.

    Article  CAS  Google Scholar 

  4. Lowe GD, Sandercock PA, Rosendaal FR. Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance? Lancet 2003; 362:504–505.

    Article  PubMed  Google Scholar 

  5. Singelyn FJ, Verheyen CCPM, Piovella F, et al. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: The EXPERT study. Anesth Analg 2007; 105:1540–1547.

    Article  PubMed  CAS  Google Scholar 

  6. Cohen A, Quinlan D. PEP trial. Pulmonary Embolism Prevention. Lancet 2000; 356:247.

    Article  PubMed  CAS  Google Scholar 

  7. Rosencher N, Bellamy L, Arnaout L. Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery? Arch Cardiovasc Dis 2009; 102:327–333.

    Article  PubMed  Google Scholar 

  8. Eriksson BI, Dahl OE, Rosencher N, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5:2178–2185.

    Article  PubMed  CAS  Google Scholar 

  9. Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007; 370:949–956.

    Article  PubMed  CAS  Google Scholar 

  10. Mega JL, Braunwald E, Mohanavelu S, et al; on behalf of the ATLASACS-TIMI 46 study group. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLASACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet 2009; 374: 29–38.

    Article  PubMed  CAS  Google Scholar 

  11. Hull RD, Pineo GF, Stein PD, et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med 2001; 161:1952–1960.

    Article  PubMed  CAS  Google Scholar 

  12. Strebel N, Prins M, Agnelli G, et al. Preoperative or postoperative start of prophylaxis for S venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162:1451–1456.

    Article  PubMed  CAS  Google Scholar 

  13. Horlocker TT. Low molecular weight heparin and neuraxial anesthesia. Thromb Res 2001; 101:141–154.

    Article  Google Scholar 

  14. Bergqvist D, Lindblad B, Matsch T. Low molecular weight heparin for thromboprophylaxis and epidural/regional anaesthesia — is there a risk? Acta Anaesthesiol Scand 1992; 36:605–609.

    Article  PubMed  CAS  Google Scholar 

  15. Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the GLORY Global Orthopaedic Registry. J Bone Joint Surg Br 2007; 89-B:799–807.

    PubMed  CAS  Google Scholar 

  16. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358:9–15.

    Article  PubMed  CAS  Google Scholar 

  17. Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000; 71:47–50.

    Article  PubMed  CAS  Google Scholar 

  18. Cohen A, Bailey CS, Alikhan R, et al. Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty. Thromb Haemost 2001; 85:940–941.

    PubMed  CAS  Google Scholar 

  19. Friedman RJ, Dunsworth GA. Cost analysis of extended prophylaxis with enoxaparin after hip arthroplasty. Clin Orthop Relat Res 2000; 370:171–182.

    Article  PubMed  Google Scholar 

  20. Demers C, Marcoux S, Ginsberg JS, et al. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998; 158:47–50.

    Article  PubMed  CAS  Google Scholar 

  21. Durica S, Raskob G, Johnson C, et al. Incidence of deep-vein thrombosis after arthroscopic knee surgery. Thromb Haemost 1997; 77(Suppl):183.

    Google Scholar 

  22. Jaureguito JW, Greenwald AE, Wilcox JF, et al. The incidence of deep venous thrombosis after arthroscopic knee surgery. Am J Sports Med 1999; 27:707–710.

    PubMed  CAS  Google Scholar 

  23. Michot M, Conen D, Holtz D, et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy 2002; 18:257–263.

    Article  PubMed  Google Scholar 

  24. Schippinger G, Wirnsberger GH, Obernosterer A, et al. Thromboembolic complications after arthroscopic knee surgery; Incidence and risk factors in 101 patients. Acta Orthop Scand 1998; 68:144–146.

    Google Scholar 

  25. Wirth T, Schneider B, Misselwitz F, et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial. Arthroscopy 2001; 17:393–399.

    Article  PubMed  CAS  Google Scholar 

  26. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecularweight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335:701–707.

    Article  PubMed  CAS  Google Scholar 

  27. Knudson MM, Morabito D, Paiement GD, et al. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 1996; 41:446–459.

    Article  PubMed  CAS  Google Scholar 

  28. Abelseth G, Buckley RE, Pineo GE, et al. Incidence of deep-vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma 1996; 10:230–235.

    Article  PubMed  CAS  Google Scholar 

  29. Elliott CG, Dudney TM, Egger M, et al. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma 1999; 47:25–32.

    Article  PubMed  CAS  Google Scholar 

  30. Fisher CG, Blachut PA, Salvian AJ, et al. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma 1995; 9:1–7.

    Article  PubMed  CAS  Google Scholar 

  31. Jørgensen PS, Warming T, Hansen K, et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res 2002; 105:477–480.

    Article  PubMed  Google Scholar 

  32. Kock H-J, Schmit-Neuerburg KP, Hanke J, et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 1995; 346:459–461.

    Article  PubMed  CAS  Google Scholar 

  33. Kujath P, Spannagel U, Habscheid W. Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis 1993; 3(Suppl 1):20–26.

    Google Scholar 

  34. Lassen MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002; 347:726–730; correspondence 2003; 348:1062.

    Article  PubMed  CAS  Google Scholar 

  35. Spannagel U, Kujath P. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast. Semin Thromb Hemost 1993; 19(Suppl 1):131–141.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Southampton University Hospitals, Southampton, UK

    David Warwick

  2. Betsi Cadwaladr University Health Board, North Wales, UK

    David Gozzard

Authors
  1. David Warwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Gozzard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Addenbrooke’s Hospital, Cambridge, UK

    David Perry

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Healthcare

About this chapter

Cite this chapter

Warwick, D., Gozzard, D. (2011). Thromboprophylaxis in orthopaedic surgery. In: Perry, D. (eds) Handbook of Thromboprophylaxis. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-00-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-00-5_5

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-907673-09-2

  • Online ISBN: 978-1-908517-00-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation